0001181431-11-061421.txt : 20111220 0001181431-11-061421.hdr.sgml : 20111220 20111220213033 ACCESSION NUMBER: 0001181431-11-061421 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20111216 FILED AS OF DATE: 20111220 DATE AS OF CHANGE: 20111220 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kennedy Joseph T CENTRAL INDEX KEY: 0001408920 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 333-176897 FILM NUMBER: 111273280 MAIL ADDRESS: STREET 1: C/O TRANSCEPT PHARMACEUTICALS, INC. STREET 2: 1003 W. CUTTING BLVD., SUITE 110 CITY: POINT RICHMOND STATE: CA ZIP: 94804 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMARIN CORP PLC\UK CENTRAL INDEX KEY: 0000897448 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: FIRST FLOOR, BLOCK 3, THE OVAL, STREET 2: SHELBOURNE ROAD, BALLSBRIDGE CITY: DUBLIN STATE: L2 ZIP: 00000 BUSINESS PHONE: 353 1 6699 020 MAIL ADDRESS: STREET 1: FIRST FLOOR, BLOCK 3, THE OVAL, STREET 2: SHELBOURNE ROAD, BALLSBRIDGE CITY: DUBLIN STATE: L2 ZIP: 00000 FORMER COMPANY: FORMER CONFORMED NAME: AMARIN PHARMACEUTICALS PLC DATE OF NAME CHANGE: 20000201 FORMER COMPANY: FORMER CONFORMED NAME: ETHICAL HOLDINGS PLC DATE OF NAME CHANGE: 19930322 3 1 rrd328236.xml FORM 3 X0204 3 2011-12-16 1 0000897448 AMARIN CORP PLC\UK AMRN 0001408920 Kennedy Joseph T C/O AMARIN PHARMA, INC. 1430 ROUTE 206, SUITE 200 BEDMINSTER NJ 07921 0 1 0 0 Senior VP and General Counsel /s/ Frederick Ahlholm, by power of attorney 2011-12-20 EX-24.TXT 2 rrd293988_331782.htm POWER OF ATTORNEY rrd293988_331782.html 
POWER OF ATTORNEY
For Executing Forms 3, 4 and 5
      Know all by these presents, that the undersigned hereby constitutes and appoints each of
Joseph Zakrzewski, John Thero and Frederick Ahlholm, each acting singly, his true and lawful
attorney-in-fact from the date hereof to:
      (1)	Execute for and on behalf of the undersigned, in the undersigned's capacity as an
officer, director and/or 10% shareholder of Amarin Corporation plc (the "Company"), forms and
authentication documents for EDGAR Filing Access;
      (2)	execute for and on behalf of the undersigned, in the undersigned's capacity as an
officer, director and/or 10% shareholder of the Company, Forms 3, 4 and 5 in accordance with
Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder;
      (3)	do and perform any and all acts for and on behalf of the undersigned that may be
necessary or desirable to complete the execution of any such Form 3, 4 or 5, complete and
execute any amendment or amendments thereto, and the timely filing of such form with the
United States Securities and Exchange Commission and any other authority; and
      (4)	take any other action of any type whatsoever in connection with the foregoing
which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interests of, or
legally required by, the undersigned, it being understood that the documents executed by such
attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such
form and shall contain such terms and conditions as such attorney-in-fact may approve in his
discretion.
      The undersigned hereby grants to each such attorney-in-fact full power and authority to
do and perform all and every act and thing whatsoever requisite, necessary, and proper to be
done in the exercise of any of the rights and powers herein granted, as fully for all intents and
purposes as the such attorney-in-fact might or could do if personally present, with full power of
substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or his
substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney
and the rights and powers herein granted.  The undersigned acknowledges that the foregoing
attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming
any of the undersigned's responsibilities to comply with Section 16 of the Securities Exchange
Act of 1934, as amended.
      This Power of Attorney shall remain in full force and effect until the undersigned is no
longer required to file Forms 3, 4, and 5 with respect to the undersigned's holdings of and
transactions in securities issued by the Company, unless earlier revoked by the undersigned in a
signed writing delivered to the foregoing attorneys-in-fact.
      By this Power of Attorney, the undersigned further revokes all previous powers of
attorney relating to the undersigned's obligations to file Forms 3, 4 and 5 in respect of the
Company's securities under Section 16(a) of the Securities Exchange Act of 1934 and related
matters.
      IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed this 13th day of December, 2011.
 /s/ Joseph T. Kennedy
Joseph T. Kennedy